Lewy Body Spectrum Disorders: from Dementia with Lewy Bodies to Parkinson’s Disease Dementia

被引:0
作者
Redden W. [1 ]
Bheemisetty S. [1 ]
机构
[1] St. Louis University Hospital, 1438 S. Grand Blvd, Saint Louis, 63104, MO
关键词
Dementia with Lewy body; Lewy body disorder; Parkinson’s disease dementia; Rapid eye movement sleep behavior disorder;
D O I
10.1007/s13670-016-0190-9
中图分类号
学科分类号
摘要
Lewy body disorders are common neurodegenerative dementias and their complex features often makes it difficult to provide an accurate diagnosis. They share neuropathological and clinical features with each other as well as with Alzheimer’s disease. There have been some recent advances in biomarkers and neuroimaging, but as of yet, nothing has been conclusive when trying to identify each dementing process. Treatment options have been limited and based on small studies; however, new options are on the horizon. In this article, we will discuss recent advances in the study of Lewy body disorders and how to apply them to clinical practice. © 2016, Springer Science+Business Media New York.
引用
收藏
页码:252 / 258
页数:6
相关论文
共 45 条
[1]  
Lippa C.F., Duda J.E., Grossman M., Et al., DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers, Neurology, 68, 11, pp. 812-819, (2007)
[2]  
Vasconcellos L.F., Pereira J.S., Parkinson’s disease dementia: diagnostic criteria and risk factor review, J Clin Exp Neuropsychol, 37, 9, pp. 988-993, (2015)
[3]  
McKeith I.G., Dickson D.W., Lowe J., Et al., Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium, Neurology, 65, pp. 1863-1872, (2005)
[4]  
Hely M.A., Reid W.G., Adena M.A., Et al., The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years, Mov Disord, 23, 6, pp. 837-844, (2008)
[5]  
Emre M., Aarsland D., Brown R., Et al., Clinical diagnostic criteria for dementia associated with Parkinson’s disease, Mov Disord, 22, pp. 1689-1707, (2007)
[6]  
McKeith I., Dementia with Lewy bodies and Parkinson’s disease with dementia: where two worlds collide, Pract Neurol, 7, pp. 374-382, (2007)
[7]  
Spillantini M.G., Schmidt M.L., Lee V.M., Et al., Alpha-synuclein in Lewy bodies, Nature, 388, pp. 839-840, (1997)
[8]  
Surendranathan A., Rowe J.B., O'Brien J.T., Neuroinflammation in Lewy body dementia, Parkinsonism Relat Disord, 21, 12, pp. 1398-1406, (2015)
[9]  
Francis P.T., Perry E.K., Cholinergic and other neurotransmitter mechanisms in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies, Mov Disord, 22, pp. 351-357, (2007)
[10]  
Biundo R., Weis L., Bostantjopoulou S., Et al., MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study, J Neural Transm, 123, pp. 431-438, (2016)